Inhaltsbereich
| 123 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
 Druckansicht
|
| Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. |
| Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T, Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lugli E, Madeo F, Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P, Melino S, Mizushima N, Moll U, Muñoz-Pinedo C, Nuñez G, Oberst A, Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG, Yuan J, Zakeri Z, Zhivotovsky B, Melino G, Kroemer G |
| Cell death and differentiation. 2014 Sep 19. pii: cdd2014137. doi: 10.1038/cdd.2014.137. pmc: PMC4262782 |
| PMID: 25236395 |
| Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. |
| Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF, Taschner PE, Hainaut P, Soussi T |
| Cancer research. 2017 Mar 2. pii: 0008-5472.CAN-16-2179. doi: 10.1158/0008-5472.CAN-16-2179 |
| PMID: 28254861 |
| Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. |
| Fagnan A, Bagger FO, Piqué-Borràs MR, Ignacimouttou C, Caulier A, Lopez C, Robert E, Uzan B, Gelsi-Boyer V, Aid Z, Thirant C, Moll U, Tauchmann S, Kurtovic-Kozaric A, Maciejewski JP, Dierks C, Spinelli O, Salmoiraghi S, Pabst T, Shimoda K, Deleuze V, Lapillonne H, Sweeney C, Mansat-De Mas V, Leite B, Kadri Z, Malinge S, de Botton S, Micol JB, Kile BT, Carmichael CL, Iacobucci I, Mullighan CG, Carroll MP, Valent P, Bernard OA, Delabesse E, Vyas P, Birnbaum D, Anguita E, Garcon L, Soler E, Schwaller J, Mercher T |
| Blood. 2020 Apr 29. pii: 454702. doi: 10.1182/blood.2019003062 |
| PMID: 32350520 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
| Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| PMID: 26040499 |
| Heterologous protein production using euchromatin-containing expression vectors in mammalian cells. |
| Zboray K, Sommeregger W, Bogner E, Gili A, Sterovsky T, Fauland K, Grabner B, Stiedl P, Moll HP, Bauer A, Kunert R, Casanova E |
| Nucleic acids research. 2015 May 14. pii: gkv475. doi: 10.1093/nar/gkv475 |
| PMID: 25977298 |
| Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. |
| Grabner B, Schramek D, Mueller KM, Moll HP, Svinka J, Hoffmann T, Bauer E, Blaas L, Hruschka N, Zboray K, Stiedl P, Nivarthi H, Bogner E, Gruber W, Mohr T, Zwick RH, Kenner L, Poli V, Aberger F, Stoiber D, Egger G, Esterbauer H, Zuber J, Moriggl R, Eferl R, Győrffy B, Penninger JM, Popper H, Casanova E |
| Nature communications. 2015 Mar 3. pii: ncomms7285. doi: 10.1038/ncomms7285. pmc: PMC4366489 |
| PMID: 25734337 |
| MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to bedside. |
| Wittig B, Schmidt M, Scheithauer W, Schmoll HJ |
| Critical reviews in oncology/hematology. 2014 Dec 19. pii: S1040-8428(14)00210-8. doi: 10.1016/j.critrevonc.2014.12.002 |
| PMID: 25577571 |
| Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. |
| Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, Tung N, Llacuachaqui M, Chornokur G, Ping S, Narod SA |
| British journal of cancer. 2013 Nov 28. pii: bjc2013741. doi: 10.1038/bjc.2013.741. pmc: PMC3899769 |
| PMID: 24292448 |
| Epidermal EGFR controls cutaneous host defense and prevents inflammation. |
| Lichtenberger BM, Gerber PA, Holcmann M, Buhren BA, Amberg N, Smolle V, Schrumpf H, Boelke E, Ansari P, Mackenzie C, Wollenberg A, Kislat A, Fischer JW, Röck K, Harder J, Schröder JM, Homey B, Sibilia M |
| Science translational medicine. 2013 Aug 22. pii: 5/199/199ra111. doi: 10.1126/scitranslmed.3005886 |
| PMID: 23966300 |
| Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial. |
| Goldner G, Bombosch V, Geinitz H, Becker G, Wachter S, Glocker S, Zimmermann F, Wachter-Gerstner N, Schrott A, Bamberg M, Molls M, Feldmann H, Pötter R |
| Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. 2009 Feb 25. doi: 10.1007/s00066-009-1970-3 |
| PMID: 19240995 |
| Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. |
| Goldner G, Tomicek B, Becker G, Geinitz H, Wachter S, Zimmermann F, Wachter-Gerstner N, Reibenwein J, Glocker S, Bamberg M, Feldmann H, Pötzi R, Molls M, Pötter R |
| International journal of radiation oncology, biology, physics. 2006 Dec 25. pii: S0360-3016(06)02823-9. doi: 10.1016/j.ijrobp.2006.08.055 |
| PMID: 17189064 |
| Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma. |
| Pashenkov M, Goëss G, Wagner C, Hörmann M, Jandl T, Moser A, Britten CM, Smolle J, Koller S, Mauch C, Tantcheva-Poor I, Grabbe S, Loquai C, Esser S, Franckson T, Schneeberger A, Haarmann C, Krieg AM, Stingl G, Wagner SN |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Dec 20. pii: 24/36/5716. doi: 10.1200/JCO.2006.07.9129 |
| PMID: 17179105 |
| 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment. |
| Goldner G, Geinitz H, Wachter S, Becker G, Zimmermann F, Wachter-Gerstner N, Glocker S, Pötzi R, Wambersie A, Bamberg M, Molls M, Feldmann H, Pötter R |
| Wiener klinische Wochenschrift. 2006 Jun 23. doi: 10.1007/s00508-006-0588-z |
| PMID: 16794760 |
| 3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects. |
| Goldner G, Zimmermann F, Feldmann H, Glocker S, Wachter-Gerstner N, Geinitz H, Becker G, Pötzi R, Wambersie A, Bamberg M, Molls M, Wachter S, Pötter R |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2005 Nov 3. pii: S0167-8140(05)00451-2. doi: 10.1016/j.radonc.2005.10.009 |
| PMID: 16271410 |
| Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study. |
| Kotsopoulos J, Huzarski T, Gronwald J, Moller P, Lynch HT, Neuhausen SL, Senter L, Demsky R, Foulkes WD, Eng C, Karlan B, Tung N, Singer CF, Sun P, Lubinski J, Narod SA |
| Breast cancer research and treatment. 2016 Jan 16. doi: 10.1007/s10549-016-3685-3. pii: 10.1007/s10549-016-3685-3 |
| PMID: 26780555 |
| Thrombophilic Risk of Individuals with Rare Compound Factor V Leiden and Prothrombin G20210A Polymorphisms: An International Case-Series of 100 Individuals. |
| Lim MY, Deal AM, Kim S, Musty MD, Conard J, Simioni P, Dutrillaux F, Eid SS, Middeldorp S, Halbmayer WM, Boneu B, Moia M, Moll S |
| European journal of haematology. 2016 Jan 16. doi: 10.1111/ejh.12738 |
| PMID: 26773706 |
| Development of a Novel Nonpeptidic (18)F-Labeled Radiotracer for in Vivo Imaging of Oxytocin Receptors with Positron Emission Tomography. |
| Wenzel B, Mollitor J, Deuther-Conrad W, Dukic-Stefanovic S, Kranz M, Vraka C, Teodoro R, Günther R, Donat CK, Ludwig FA, Fischer S, Smits R, Wadsak W, Mitterhauser M, Steinbach J, Hoepping A, Brust P |
| Journal of medicinal chemistry. 2016 Feb 3. doi: 10.1021/acs.jmedchem.5b01080 |
| PMID: 26796795 |
| Adjuvant treatment with pegylated interferon alpha-2a versus low-dose interferon alpha-2a in patients with high-risk melanoma. A randomized phase III DeCOG trial. |
| Eigentler TK, Gutzmer R, Hauschild A, Heinzerling L, Schadendorf D, Nashan D, Hölzle E, Kiecker F, Becker J, Sunderkötter C, Moll I, Richtig E, Pönitzsch I, Pehamberger H, Kaufmann R, Pföhler C, Vogt T, Berking C, Praxmarer M, Garbe C |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 Jun 10. pii: mdw225. doi: 10.1093/annonc/mdw225 |
| PMID: 27287206 |
| Unexpected oncosuppressive role for STAT3 in KRAS-induced lung tumorigenesis. |
| Grabner B, Moll HP, Casanova E |
| Molecular & cellular oncology. 2015 May 26. doi: 10.1080/23723556.2015.1036199. pii: 1036199 |
| PMID: 27314069 |
| ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. |
| Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 Jul 5. pii: mdw235. doi: 10.1093/annonc/mdw235 |
| PMID: 27380959 |
| 123 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
